Axsome Therapeutics (AXSM) Stock Forecast & Price Target

AXSM$141.69-2.68 -1.86%
BiotechnologyGrowth Stock
Compare
Market cap$7.45BEnterprise value$7.50BRevenue (TTM)$865.27MMarket position—

Score

65
Bullish
Value
57
Quality
38
Growth
100

Axsome Therapeutics, Inc. price target

AXSM
Low$238.00
Average$279.25
High$380.00
Upside vs current price+97.1%

The average target of $279.25 is +97.1% versus the current AXSM price of $141.69.

Axsome Therapeutics, Inc. analyst ratings

RatingAnalysts
Strong buy3
Buy18
Hold1
Sell0
Strong sell0
ConsensusBuy

22 analysts cover AXSM.

Axsome Therapeutics, Inc. EPS and revenue estimates

The estimate table for the Axsome Therapeutics, Inc. keeps 2026 EPS $-2.56, 2027 EPS $3.52, and years with fewer than three analysts are not filled in.

Fiscal yearEPS estimateRevenue estimate
2026$-2.56$954.09M
2027$3.52$1.46B

Is Axsome Therapeutics, Inc. a buy or sell?

Of the 22 analysts covering Axsome Therapeutics, Inc., 21 rate it a buy (3 strong buy and 18 buy), 1 rates it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The AXSM consensus label is Buy, beside 21 buy-side ratings and 0 sell-side ratings.

The average target of $279.25 implies +97.1% versus the current price of $141.69.

the Axsome Therapeutics, Inc. closes with 21 buy-side ratings and 0 on the sell side. The headcount is Buy.

Reading the Axsome Therapeutics, Inc. forecast

Analysts are far apart on AXSM. The published low is $238.00, the average is $279.25, and the high is $380.00.

From today's $141.69 print, the AXSM average target is +97.1% away.

Most of the AXSM coverage agrees: 21 of 22 analysts are on the buy side, 1 is at hold, and 0 are on the sell side, and the published consensus is Buy.

AXSM targets have eased: $242.33 in the last month against $260.14 over the last quarter.

Coverage of AXSM is broad at 22 analysts, and the average is a crowd rather than a single desk.

Axsome Therapeutics, Inc. forecast questions

What is the AXSM price target?

The published range for AXSM is $238.00 to $380.00, with an average of $279.25. That average is +97.1% versus the current price of $141.69.

Is Axsome Therapeutics, Inc. a buy or sell?

Of the 22 analysts covering Axsome Therapeutics, Inc., 21 rate it a buy, 1 rates it a hold, and 0 rate it a sell. The consensus is Buy, which for AXSM is 21 on the buy side, 1 at hold, and 0 on the sell side.

What is the EPS estimate for Axsome Therapeutics, Inc.?

Analyst EPS estimates for Axsome Therapeutics, Inc.: 2026 $-2.56, 2027 $3.52.

What is the revenue estimate for Axsome Therapeutics, Inc.?

Analyst revenue estimates for Axsome Therapeutics, Inc.: 2026 $954.09M, 2027 $1.46B.

How many analysts cover AXSM?

22 analysts cover AXSM. Their consensus on AXSM is Buy, across those 22.

AXSM price $141.69 -2.68 -1.86%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener